Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study
BackgroundOur previous work has demonstrated the benefits of transcutaneous immunization in targeting Langerhans cells and preferentially inducing CD8 T-cell responses.MethodsIn this randomized phase Ib clinical trial including 20 HIV uninfected volunteers, we compared the safety and immunogenicity...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.586124/full |